Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    An Evaluation of the Antibacterial, Anti-Giardial, Anticancer and Toxicity Properties of Selected Nut Extracts

    wadmin2By wadmin2March 5, 2016Updated:August 11, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Pauline Lebaratoux1,2, Joseph Sirdaarta1,3, Paran Rayan1,3, Pauline Ann McDonnell1, Ian Edwin Cock1,3*
    1School of Natural Sciences, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.
    2School of Biology, Ecole de BiologieIndustrielle (EBI), Cergy, FRANCE.
    3Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.

    Pharmacognosy Communications,2016,6,3,174-184.
    DOI:10.5530/pc.2016.3.7
    Published: March 2016
    Type: Original Article

    ABSTRACT

    Background: Foods with high oil and fatty acid contents have been linked with a variety of medicinal properties including bacterial growth inhibition, anti-Giardial activity and the inhibition of cancer cell proliferation. Almond, cashew, hazelnut and walnut contain very high fatty acid contents. Despite this, these nuts have not been adequately screened for medicinal properties. Materials and Methods: Almond, cashew, hazelnut and walnut powders were extracted and tested for antimicrobial activity using modified disc diffusion and MIC methods. Inhibitory activity against the gastrointestinal protozoal parasite Giardia duodenalis and against CaCo2 cancer cells were evaluated using colorimetric cell proliferation assays. Toxicity was evaluated using an Artemia franciscana nauplii bioassay. Results: The methanolic almond and walnut solvent extractions displayed broad spectrum growth inhibitory activity, inhibiting the growth of 100% and 7 of the 11 (64%) bacterial strains tested respectively. The methanolic walnut extract was a particularly potent growth inhibitor, with MIC values of ~1000 μg/mL, 700 μg/mL and 800 μg/mL against A. baylyi, P. mirabilis and P. vulgaris respectively. The methanolic almond extract also had moderate to inhibitory activity against E. coli (MIC ~2000 μg/mL), P. mirabilis and P. vulgaris (both ~2500 μg/mL). The methanolic cashew and hazelnut extracts were moderate inhibitors of E. coli growth (~2500 and 1250 μg/mL respectively). The methanolic almond extract was also a potent inhibitor of G. duodenalis proliferation (IC50 878 μg/mL). All extracts were ineffective at blocking the growth of the colorectal cancer cell line CaCo2. Instead, most of the extracts substantially stimulated proliferation. All of the nut extracts were non-toxic in the Artemia nauplii bioassay. Conclusion: The bacterial growth inhibitory activities of the methanolic almond and walnut extracts, the anti-Giardial activity of the methanolic almond extract and their lack of toxicity indicates the potential of these extracts in the discovery and development of new natural antibiotic agents.

    Key words: Antibacterial activity, Giardia duodenalis, Anti-proliferative activity, CaCo2, Anticancer activity, Artemia, Toxicity.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up